Melissa Hodeib

912 total citations · 1 hit paper
26 papers, 653 citations indexed

About

Melissa Hodeib is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Melissa Hodeib has authored 26 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in Melissa Hodeib's work include Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cervical Cancer and HPV Research (5 papers). Melissa Hodeib is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cervical Cancer and HPV Research (5 papers). Melissa Hodeib collaborates with scholars based in United States and South Korea. Melissa Hodeib's co-authors include Robert E. Bristow, Jenny Chang, Suk‐Joon Chang, Erin E. Hahn, Quyen Ngo‐Metzger, Devansu Tewari, Chun Chao, Brian S. Mittman, Lanfang Xu and Mona Saraiya and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Melissa Hodeib

24 papers receiving 646 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis

2013 321 citations Melissa Hodeib, Jenny Chang et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Hodeib United States	11	338	272	213	193	134	26	653
Roni Nitecki United States	15	340 1.0×	171 0.6×	180 0.8×	253 1.3×	101 0.8×	50	709
Leslie Bradford United States	16	234 0.7×	198 0.7×	237 1.1×	285 1.5×	220 1.6×	46	712
Clare J. Reade Canada	13	271 0.8×	135 0.5×	114 0.5×	329 1.7×	174 1.3×	34	576
Audrey Tieko Tsunoda Brazil	14	172 0.5×	134 0.5×	179 0.8×	345 1.8×	154 1.1×	47	618
Sarikapan Wilailak Thailand	16	311 0.9×	204 0.8×	242 1.1×	305 1.6×	242 1.8×	59	870
Jason Dodge Canada	14	646 1.9×	292 1.1×	173 0.8×	495 2.6×	77 0.6×	27	930
Beryl Manning‐Geist United States	13	178 0.5×	139 0.5×	112 0.5×	122 0.6×	46 0.3×	49	458
Katharine M. Esselen United States	15	202 0.6×	92 0.3×	134 0.6×	174 0.9×	138 1.0×	39	621
Marilyn Huang United States	16	295 0.9×	211 0.8×	229 1.1×	437 2.3×	115 0.9×	96	802
Luca Giannella Italy	18	298 0.9×	137 0.5×	113 0.5×	395 2.0×	299 2.2×	72	808

Countries citing papers authored by Melissa Hodeib

Since Specialization

Citations

This map shows the geographic impact of Melissa Hodeib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Hodeib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Hodeib more than expected).

Fields of papers citing papers by Melissa Hodeib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Hodeib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Hodeib. The network helps show where Melissa Hodeib may publish in the future.

Co-authorship network of co-authors of Melissa Hodeib

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Hodeib. A scholar is included among the top collaborators of Melissa Hodeib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Hodeib. Melissa Hodeib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mukherjee, Amrita, Lanfang Xu, Kimberly L. Cannavale, et al.. (2025). Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery System. Cancer Management and Research. Volume 17. 281–291.

Chao, Chun, Erin E. Hahn, Ernest Shen, et al.. (2025). A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare system. Implementation Science. 20(1). 21–21.

Mukherjee, Amrita, Lanfang Xu, Kimberly L. Cannavale, et al.. (2024). Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer. Frontiers in Oncology. 14. 1290719–1290719. 2 indexed citations

Chao, Chun, Erin E. Hahn, Devansu Tewari, et al.. (2022). A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemporary Clinical Trials. 124. 106994–106994. 1 indexed citations

Amneus, M., et al.. (2022). Clinical use of PARP inhibitor in recurrent uterine leiomyosarcoma with presence of a somatic BRCA2 mutation. Gynecologic Oncology Reports. 42. 101044–101044. 10 indexed citations

Hahn, Erin E., Corrine Munoz‐Plaza, Chunyi Hsu, et al.. (2021). De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. SHILAP Revista de lepidopterología. 2(1). 108–108. 10 indexed citations

Miller, Maureen J., Lanfang Xu, Jin Qin, et al.. (2021). Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020. MMWR Morbidity and Mortality Weekly Report. 70(4). 109–113. 115 indexed citations

Nguyen, Michelle T., et al.. (2020). Ovarian Solid Pseudopapillary Tumor Resembling Benign Hemorrhagic Cyst on Rapid Frozen Section. Case Reports in Obstetrics and Gynecology. 2020(1). 6473630–6473630. 4 indexed citations

Dessources, Kimberly, et al.. (2019). Optimization of acute healthcare resource utilization using cervical cancer care navigation. Gynecologic Oncology. 154(1). e3–e3. 1 indexed citations

10.

Hodeib, Melissa, et al.. (2018). Sebaceous carcinoma arising within an ovarian mature cystic teratoma: A case report with discussion of clinical management and genetic evaluation. Gynecologic Oncology Reports. 26. 37–40. 7 indexed citations

11.

Hodeib, Melissa, et al.. (2017). Comprehensive genomic profiling of rare gynecological malignancies. Gynecologic Oncology. 145. 212–212. 1 indexed citations

12.

Hodeib, Melissa, Martin P. Ogrodzinski, Laurent Vergnes, et al.. (2017). Metformin and phenformin inhibit cell proliferation and alter metabolism in high-grade serous ovarian cancer(HGSC). Gynecologic Oncology. 145. 119–119. 1 indexed citations

13.

Hodeib, Melissa, Joshua G. Cohen, B.J. Rimel, et al.. (2016). Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN. Gynecologic Oncology. 141(3). 507–510. 48 indexed citations

14.

Walsh, Christine & Melissa Hodeib. (2015). Leveraging DNA repair deficiency in gynecologic oncology. Current Opinion in Obstetrics & Gynecology. Publish Ahead of Print(1). 24–31. 2 indexed citations

15.

Hodeib, Melissa, Jenny Chang, Fong Liu, et al.. (2015). Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecologic Oncology. 138(1). 121–127. 52 indexed citations

16.

Bristow, Robert E., Melissa Hodeib, Alan Smith, et al.. (2013). Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass. American Journal of Obstetrics and Gynecology. 209(6). 581.e1–581.e8. 15 indexed citations

17.

Hodeib, Melissa, et al.. (2013). Impact of complete cytoreduction to no gross residual disease on survival in patients with advanced ovarian cancer: A meta-analysis. Gynecologic Oncology. 131(1). 249–249. 1 indexed citations

18.

Hu, Zhong-Ting, et al.. (2010). An Alternative Technology to Prepare Tissue Microarray Using Frozen Tissue Samples. Methods in molecular biology. 664. 81–91. 2 indexed citations

19.

Kore, Anilkumar R., Melissa Hodeib, & Zhong-Ting Hu. (2008). Chemical Synthesis of LNA-mCTP and Its Application for MicroRNA Detection. Nucleosides Nucleotides & Nucleic Acids. 27(1). 1–17. 16 indexed citations

20.

Zhou, Lei, et al.. (2007). New tissue microarray technology for analyses of gene expression in frozen pathological samples. BioTechniques. 43(1). 101–105. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact